Curet Myriam 4

What Happened
Myriam Curet, a director of Inspire Medical Systems, was granted 3,562 restricted stock units (RSUs) on April 30, 2026. The award is reported as an acquisition at $0.00 per share (code A), meaning no cash was paid. These RSUs represent a contingent right to receive common shares if and when they vest.

Key Details

• Transaction date: 2026-04-30; Filing date: 2026-05-04 (appears to be filed 4 days after the transaction — later than the usual 2-business-day Form 4 deadline).
• Award: 3,562 RSUs; reported price $0.00 (award/grant, not an open-market purchase).
• Shares owned after transaction: Not specified in the provided filing details.
• Footnote: RSUs vest on the earlier of (a) the first anniversary of the grant or (b) immediately prior to a Change of Control under the 2018 Incentive Award Plan, in each case contingent on Curet’s continued service.
• Transaction code: A = Award/Grant.

Context
RSU grants are a form of compensation and do not immediately transfer tradable shares; the recipient only receives shares if the RSUs vest per the plan terms. Such grants are common for executives and directors and are not the same signal as an open-market purchase or sale. The apparent late filing is procedural — late Form 4s can attract SEC attention and are relevant for compliance records but do not by themselves indicate intent about the company’s prospects.